Status:
COMPLETED
An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial Hypertension
Lead Sponsor:
AstraZeneca
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This study is aimed to evaluate response rate of the antihypertensive treatment with a calcium antagonist in real life practice, to evaluate patients' quality of life and to collect the following Serb...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subject population with essential arterial hypertension currently receiving treatment with a calcium antagonist
Exclusion
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01201980
Start Date
December 1 2010
End Date
December 1 2011
Last Update
January 10 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Belgrade, Serbia
2
Research Site
Čačak, Serbia
3
Research Site
Kamenitz, Serbia
4
Research Site
Kragujevac, Serbia